You will now be redirected to the GD3 website
Invivotek is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3SERVICES
Oncology & Immuno-Oncology
Efficacy Studies in Xenograft and Syngeneic Cancer Models in Mice
Our Oncology program for evaluation of test compounds in xenograft and syngeneic tumor models in mice offers a unique suite of technologies, scientific expertise and technical skills for monitoring of primary and metastatic tumor growth in vivo:
- Years of experience in the field of Oncology and Immune Oncology
- Sophisticated surgery techniques for orthotopic tumor implantation and primary tumor excision
- Experience with xenograft tumor models in humanized mice
- Advanced expertise in FACS analysis of tumor infiltrating lymphocytes
- Pioneers in biophotonic imaging for tracking orthotopic and metastatic tumor growth
- Biochemical capabilities for multiplex analyses of cytokines, hormones and other analytes
- Multidisciplinary scientific team with extensive experience in evaluation of a broad range of compounds and biologics in efficacy studies
Each study is custom-designed to best meet individual client needs. Interpretive data analysis and summary reports are provided at the completion of each study.